Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT00832507 · TERMINATED
Trial details
- NCT number
- NCT00832507
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-10-01
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.